| Item type |
デフォルトアイテムタイプ_（フル）(1) |
| 公開日 |
2023-03-18 |
| タイトル |
|
|
タイトル |
Autism phenotype in fragile X premutation males is not associated with FMR1 expression: a preliminary evaluation |
|
言語 |
en |
| 作成者 |
Sumekar, Tanjung Ayu
Winarni, Tri Indah
Mu, Yi
Chonchaiya, Weerasak
Tassone, Flora
Iwahashi, Christine
Cheung, Katherine
Mh Faradz, Sultana
Hagerman, Paul J
Nguyen, Danh V
Hagerman, Randi J
|
| アクセス権 |
|
|
アクセス権 |
open access |
|
アクセス権URI |
http://purl.org/coar/access_right/c_abf2 |
| 権利情報 |
|
|
権利情報 |
Copyright (c) 2018 Hiroshima University Medical Press |
| 主題 |
|
|
主題Scheme |
Other |
|
主題 |
Autism |
| 主題 |
|
|
主題Scheme |
Other |
|
主題 |
CGG |
| 主題 |
|
|
主題Scheme |
Other |
|
主題 |
FMR1 mRNA |
| 主題 |
|
|
主題Scheme |
Other |
|
主題 |
FMRP |
| 主題 |
|
|
主題Scheme |
Other |
|
主題 |
Fragile-X Premutation |
| 主題 |
|
|
主題Scheme |
NDC |
|
主題 |
490 |
| 内容記述 |
|
|
内容記述 |
To explore the association between autism phenotype and FMR1 protein (FMRP), FMR1 mRNA and CGG repeat length in 31 male FMR1 premutation carriers aged 3.0 to 27.9 years old (mean 13.0 ± SD 6.5) using the ADOS communication, social interactive and total scores. FMRP levels were determined using the sandwich Enzyme-linked Immunosorbent Assay (ELISA) method, FMR1 mRNA expression levels were measured by qRT-PCR, and CGG repeat size was determined using Southern blot and PCR analyses. There was no significant difference in FMRP, CGG repeat length, and FMR1 mRNA between fifteen subjects without (ASD / PDDNOS / autism and sixteen subjects with ASD / PDDNOS / autism. ADOS scores were not significantly associated with either FMRP or FMR1 mRNA, This preliminary evaluation found that autism phenotype is not associated with the level of expression of either FMR1 mRNA or FMRP. However, CGG was significantly negative associated with both ADOS communication score (p= 0.0173) and ADOS total score (p= 0.0358). |
|
言語 |
en |
| 内容記述 |
|
|
内容記述タイプ |
Other |
|
内容記述 |
This work was supported by National Institute of Health grants HD036071, HD02274, DE019583, DA024854, AG032119, AG032115, MH77554; National Center for Advancing Translational Sciences grant UL1RR024146 and UL1TR000153; and Health and Human Services Administration of Developmental Disabilities grant 90DD05969. |
| 出版者 |
|
|
出版者 |
Hiroshima University Medical Press |
| 言語 |
|
|
言語 |
eng |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
departmental bulletin paper |
| 出版タイプ |
|
|
出版タイプ |
VoR |
|
出版タイプResource |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| 収録物識別子 |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
0018-2052 |
| 収録物識別子 |
|
|
収録物識別子タイプ |
NCID |
|
収録物識別子 |
AA00664312 |
| 開始ページ |
|
|
開始ページ |
166 |
| 書誌情報 |
Hiroshima Journal of Medical Sciences
Hiroshima Journal of Medical Sciences
巻 67,
p. 166-173,
発行日 2018-05
|
| 旧ID |
45861 |
HiroshimaJMedSci_67s_166.pdf (240.3 KB)
